Related references
Note: Only part of the references are listed.Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions
John E. Pearson et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
Mechanisms of HIV Latency: an Emerging Picture of Complexity
David M. Margolis
Current HIV/AIDS Reports (2010)
Pharmaceutical approaches to eradication of persistent HIV infection
Mary-Catherine Bowman et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Modeling HIV persistence, the latent reservoir, and viral blips
Libin Rong et al.
JOURNAL OF THEORETICAL BIOLOGY (2009)
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Reuben M. Granich et al.
LANCET (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Mayte Coiras et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Mari M. Kitahata et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants.
Avy Violari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HIV rebounds from latently infected cells, rather than from continuing low-level replication
Beda Joos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Optimal drug treatment regimens for HIV depend on adherence
O. Krakovska et al.
JOURNAL OF THEORETICAL BIOLOGY (2007)
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
Hwijin Kim et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART
LE Jones et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2005)
Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy
J Macias et al.
JOURNAL OF INFECTION (2005)
Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: Expression of archival virus and replication of virus
NH Tobin et al.
JOURNAL OF VIROLOGY (2005)
Duration of an intermittent episode of viremia
M Di Mascio et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2005)
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients
D Monie et al.
JOURNAL OF VIROLOGY (2005)
Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART
RE Nettles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The multifactorial nature of HIV-1 latency
K Lassen et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Immune responses to Listeria monocytogenes
EG Pamer
NATURE REVIEWS IMMUNOLOGY (2004)
Enumeration of latently infected CD4(+) T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay
JM Fondere et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Viral blip dynamics during highly active antiretroviral therapy
M Di Mascio et al.
JOURNAL OF VIROLOGY (2003)
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years
DV Havlir et al.
JOURNAL OF VIROLOGY (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-Cell decay in vivo
M Markowitz et al.
JOURNAL OF VIROLOGY (2003)
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months
M Di Mascio et al.
JOURNAL OF VIROLOGY (2003)
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification
PA Sklar et al.
AIDS (2002)
Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection
V Müller et al.
JOURNAL OF VIROLOGY (2002)
Quantification of intrinsic residual viral replication in treated HIV-infected patients
C Fraser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications
C Fraser et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years
HF Günthard et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Generation of HIV latency during thymopoiesis
DG Brooks et al.
NATURE MEDICINE (2001)
Production of resistant HIV mutants during antiretroviral therapy
RM Ribeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
HF Günthard et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
